Can a simple tool reduce pancreatitis risk during ERCP?

NCT ID NCT05336630

Completed Symptom relief Sponsor: Dartmouth-Hitchcock Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using forceps to help guide a tube into the bile duct during an ERCP procedure makes the process easier and reduces the chance of pancreatitis afterward. 152 patients were randomly assigned to either standard cannulation or forceps-assisted cannulation. The goal was to see if the forceps group had fewer difficult cannulations and less post-ERCP pancreatitis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Forceps (medical device used to grab tissue and assist cannulation during ERCP)
What this could lead to: If successful, this technique could make ERCP procedures easier and safer, potentially lowering the risk of post-procedure pancreatitis.
What could go wrong: This is a small, completed study with 152 participants. The forceps technique may not reduce pancreatitis risk significantly, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-ERCP ACUTE PANCREATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute pancreatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-ERCP ACUTE PANCREATITIS

Contacts and locations

Locations

Dartmouth Health

Lebanon, New Hampshire, 03756, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.